Regulation on Farsalinos

The Global Regulatory Paradox of Cannabis Versus Nicotine

Sun, 06 Sep 2026 00:00:00 +0000

A new Harm Reduction Journal paper by Konstantinos Farsalinos argues that global drug policy has become internally inconsistent, and the application of double standards is becoming the new “norm”.

Key Takeaways
#

Cannabis, a psychoactive substance linked to real risks of psychosis and cognitive decline, is rolling out globally under the promise of personal freedom.
At the same time, non-combustible nicotine products—like vapes, pouches, and snus, which don’t intoxicate and carry far lower toxicological risks than smoking—are getting banned or criminalized in dozens of countries.
This contradiction has been labeled a “regulatory paradox.” In both cases, it’s the combustion, not the drug itself, that drives most of the harm, yet policy treats them as opposites.
From a toxicological standpoint, smoke is smoke; cannabis smoke shares carcinogens and toxic pathways with tobacco smoke and may even deliver more tar per puff. Yet the restrictions focus on nicotine’s non-combustible forms while leaving cannabis smoking largely unchecked.
Neurocognitively, nicotine acts as a non-intoxicating stimulant with proven cognitive benefits like sharpened attention and working memory, whereas THC carries a well-documented, dose-dependent link to acute psychosis and cognitive impairment.
A double standard protecting youth runs through both markets: flavor bans and “gateway theory” fears are weaponized against vapes and pouches, while flavored, youth-appealing THC edibles and vapes proliferate with little regulatory pushback.
Sociologically, the “Iron Law of Prohibition” is playing out again: Australia’s 2024 e-cigarette restrictions coincided with an estimated 95.7% of its vape market going illicit—the same black-market dynamic regulators previously accepted as a lesson from cannabis and alcohol prohibition.
Bioethically, cannabis legalization is defended through “cognitive liberty” and adult autonomy, while nicotine regulation has swung toward “hard paternalism,” treating addiction as negating free will and denying smokers access to lower-risk substitutes. The comparison of dependence also contradicts the policy trend.
While nicotine has a higher capture rate among first-time users, cannabis use disorder is more prevalent at a population level and includes a clinically validated withdrawal syndrome, undercutting the idea that cannabis is simply the “safe” substance and nicotine the dangerous one.
Economically and in criminal-justice terms, the paper argues nicotine bans reproduce the very costs cannabis liberalization was meant to avoid: lost tax revenue, destroyed legitimate businesses, and enforcement resources funneled into policing a black market instead of advancing public health.

The Core Claim, Up Front
#

The argument is straightforward: if you separate THC and nicotine from their traditional delivery systems—smoked cannabis and combustible cigarettes—the toxicology simply doesn’t support current policy. Combustion, not the drug itself, is the primary driver of harm in both scenarios. Yet policy has moved in opposite directions: cannabis is heading toward liberalization, while nicotine is facing prohibition of exactly the products—e-cigarettes, snus, and pouches—that remove combustion from the equation.

News-Week, August 27 - September 04, 2026

Fri, 04 Sep 2026 00:00:00 +0000

US Courts Diverge, EU Grinds to a Halt: Nicotine Policy Slips Into Open Confrontation

Headline Points
#

New York State enacted a 75% wholesale tax on tobacco-free nicotine pouches taking effect September 1, 2026. Distributors must also settle a retroactive floor tax on stock already on hand by September 21.
Australia’s federal Opposition put forward a plan to slash the national tobacco excise by 80% and bring regulated adult sales of e-cigarettes and nicotine pouches out from behind pharmacy-only restrictions. The stated aim is to erode the margins of an illicit trade that, by the Coalition’s reckoning, now accounts for as much as 80% of all tobacco consumed in the country.

How Australia has Lost Control of the Nicotine Market?

Sun, 30 Aug 2026 00:00:00 +0000

“When Best Practice Falls Short.” Australia has long been praised as a world leader in tobacco regulation, shaping global standards via plain packaging and strong public‑health initiatives. Yet this image hides a serious strategic misstep. By rigidly following WHO‑endorsed “best practice” measures—namely heavy excise taxes and a medical‑only framework for nicotine vapes—Australia has unintentionally sparked a sovereignty crisis. The government has effectively abandoned its duty to oversee the market, handing control over to criminal networks.

The Global State of Tobacco Harm Reduction 2026

Sat, 29 Aug 2026 00:00:00 +0000

A 91-page situation report from Knowledge•Action•Change was recently released, the Global State of Tobacco Harm Reduction (GSTHR) 2026, covering tobacco harm reduction (THR) developments from January 2025 into early 2026. This report represents a single synthesis of data on smoking prevalence, safer nicotine product use, regulation, pricing, science and policy across more than 200 countries, and is released approximately every 2 years.

The Core Findings
#

Five findings define this edition:

News-Week, August 20–26, 2026

Fri, 28 Aug 2026 00:00:00 +0000

Covering news published August 20–26, 2026

Regulators, Researchers Issue Dueling Signals on Safer Nicotine Products
#

U.S. regulators kept expanding the market for lower-risk nicotine products in the final week of August 2026, even as major pediatric and public health bodies published sobering evidence on vaping’s effects on young people — and a landmark evidence review reaffirmed vaping’s edge as a quit-smoking tool for adults.

UK Tightens the Rules on Vaping and Nicotine Products

Fri, 28 Aug 2026 00:00:00 +0000

The UK government has published new guidance setting out a significant overhaul of the rules governing the sale of vaping and nicotine products across England, Wales, Scotland and Northern Ireland. The changes, issued by the Department of Health and Social Care, take effect on 29 October 2026 and mark one of the most sweeping updates to nicotine retail law in the UK to date.

A single, UK-wide age of sale
#

The headline change is a unified minimum age of sale of 18 for all vaping and nicotine products, closing gaps that previously existed between nations and product types. In England, Wales and Northern Ireland, age restrictions had only applied to nicotine-containing vapes; from October, they will extend to non-nicotine vapes as well. Scotland already restricted both nicotine and non-nicotine vapes, but will now also bring nicotine products more broadly into scope — including nicotine pouches, nicotine strips and nicotine pearls, along with synthetic nicotine.

The Global Paradox

Mon, 24 Aug 2026 00:00:00 +0000

Why Cigarettes Are Everywhere But Non-Combustible Nicotine Alternatives Are Banned? Here’s something that should make you stop and think: In 2026, you can walk into almost any store worldwide and buy a pack of cigarettes - a product that kills up to half of its long-term users. But try to buy a vape or nicotine pouch to help quit smoking, and you might be breaking the law.

This is a global pattern that defies logic and costs lives.